- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02812186
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Effect of Deep Versus Moderate Neuromuscular Blockade on Peak Airway Pressures During Elective Laparoscopic Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Neuromuscular blockade (NMB) is frequently utilized in laparoscopic procedures to improve surgical conditions by relaxing the abdominal muscles and thus facilitating insufflation with carbon dioxide to optimize surgical view. Increased airway pressures can lead to an increase in alveolar and perivascular edema, a decline in dynamic lung compliance and hypoxemia.
Several studies have investigated surgical view under deep vs. moderate neuromuscular blockade. Literature supports deep neuromuscular blockade providing better operating conditions/view by a surgeon and low airway pressures but, potentially, longer duration to extubation and worse respiratory mechanics at the end of anesthesia versus moderate neuromuscular blockade which shows worse operating conditions/view by a surgeon and worse airway pressures but possibly shorter duration to extubation and better respiratory mechanics at the end of anesthesia.
Thus, there is clearly equipoise with regard to the comparative effectiveness of deep vs medium NMB. Therefore, this study is designed to ascertain if a deep neuromuscular block will decrease the airway pressures in patients undergoing laparoscopic procedures compared to those under a moderate block. A reduction in airway pressures may lead to a decrease in the complications associated with elevated airway pressures including hypoxemia, total static lung compliance, alveolar edema, and long term morbidity. Additionally, the study aims to determine if time from administration of sugammadex to reversal is different between patients that have a moderate NMB as compared to a deep NMB.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
New York
-
Stony Brook, New York, United States, 11794
- Stony Brook University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Each participant must be willing and able to provide written informed consent for the study.
- Each participant must be American Society of Anesthesiologists (ASA) class I, II or III.
- Each participant must be scheduled for elective laparoscopic surgery (this includes robotic laparoscopic surgery).
- Expected surgical duration of 60 min or longer
Exclusion Criteria:
- Inability to give informed oral or written consent
- Known or suspected neuromuscular disorders impairing neuromuscular function;
- True allergies as defined as hypotension, bronchospasm, or anaphylaxis to muscle relaxants, anesthetics or opioids
- A history (patient or family) of malignant hyperthermia
- A contraindication for neostigmine administration
- Renal insufficiency, as defined by serum creatinine levels at 2.5 fold the normal level
- Body mass index >40 kg/m^2
- Significant respiratory disease.
- Planned postoperative mechanical ventilation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Deep to Moderate NMB
This group will undergo deep neuromuscular blockade, defined as post tetanic count (PTC) of 1 to 2, in the beginning portion of the surgery followed by a period of moderate blockade.
|
Rocuronium infusion will be paused and the Train of Four (TOF) monitor will be set to every 1-2 min.
Once the patient has achieved a "moderate" NMB state (one to two twitches), the infusion of the muscle relaxant will be resumed at a low dose to maintain the patient at this level of blockade.
|
|
Other: Moderate to Deep NMB
This group will undergo moderate neuromuscular blockade, defined as 1-2 twitches, in the beginning portion of the surgery followed by a period of deep blockade.
|
Rocuronium infusion will be increased in increments of 0.1-0.2
mg/kg/hr.
and the TOF monitor will be set to every 1-2 min.
Once the patient has no twitches and a PTC of 0-1 ("deep" NMB) the infusion will be adjusted to maintain the patient at this level of NMB.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Airway Pressures
Time Frame: Intra-operative, from intubation time to extubation time
|
To determine if a deep NMB can lead to lower peak airway pressures in patients undergoing laparoscopic procedures when compared to a moderate NMB
|
Intra-operative, from intubation time to extubation time
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abdominal Insufflation Pressure
Time Frame: Intra-operative, from intubation time to extubation time
|
To compare surgical operating condition by Abdominal Insufflation Pressure in patients undergoing laparoscopic procedures using deep NMB versus moderate NMB
|
Intra-operative, from intubation time to extubation time
|
|
Surgical Rating Scale
Time Frame: Intra-operative, from intubation time to extubation time
|
To compare surgical operating condition by Surgical Rating Scale (SRS) in patients undergoing laparoscopic procedures using deep NMB versus moderate NMB Surgical Rating Score scores are on a 1-5 scale with 1 = extremely poor conditions, 2 = poor conditions, 3 = adequate conditions, 4 = good conditions, 5= excellent conditions. Higher scores mean a better outcome. |
Intra-operative, from intubation time to extubation time
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ruchir Gupta, MD, Stony Brook Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Urologic Diseases
- Uterine Diseases
- Gastrointestinal Diseases
- Renal Insufficiency
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Gallbladder Diseases
- Biliary Tract Diseases
- Pelvic Organ Prolapse
- Kidney Diseases
- Renal Insufficiency, Chronic
- Endometriosis
- Prolapse
- Cholecystitis
- Intestinal Obstruction
- Uterine Prolapse
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Neuromuscular Agents
- Neuromuscular Nondepolarizing Agents
- Neuromuscular Blocking Agents
- Rocuronium
Other Study ID Numbers
- 823925
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on Rocuronium
-
Radboud University Medical CenterMerck Sharp & Dohme LLCUnknown
-
Clare Hayes-BradleyNot yet recruitingInduction of Anaesthesia | Rocuronium | Muscle Relaxants
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
Medtronic - MITGCompletedAnesthesia | Neuromuscular BlockadeUnited States
-
University of RostockCompletedObservation of Neuromuscular Block | Complication of Ventilation TherapyGermany
-
Sheba Medical CenterUnknown
-
Pontificia Universidad Catolica de ChileCompletedNeuromuscular Blockade
-
Rigshospitalet, DenmarkCompletedA Comparison of Rocuronium 0.3 mg/kg, and 0.9 mg/kg for Induction of Anesthesia in Elderly Patients.Anesthesia | Intubation Complication | Neuromuscular Blockade | Neuromuscular Blockade, ResidualDenmark
-
SMG-SNU Boramae Medical CenterUnknownSore ThroatKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted